Most of the patients have shown good response after treatment with DEC. Despite treatment, mild interstitial lung disease has been found to persist in some patients. Studies have shown that almost 20% of patients may relapse in five years.

Patients developing pulmonary hypertension may have a poor prognosis because, most of the time, it is irreversible.